Artal Group as of June 30, 2021
Portfolio Holdings for Artal Group
Artal Group holds 144 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ww Intl | 10.9 | $536M | 15M | 36.14 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 6.6 | $327M | 71M | 4.59 | |
| Beigene Sponsored Adr (ONC) | 5.9 | $292M | 850k | 343.19 | |
| Citigroup Com New Call Option (C) | 3.9 | $195M | 2.8M | 70.75 | |
| Seer Com Cl A (SEER) | 3.7 | $183M | 5.6M | 32.78 | |
| Acceleron Pharma | 3.6 | $176M | 1.4M | 125.49 | |
| Argenx Se Sponsored Adr (ARGX) | 3.1 | $151M | 500k | 301.07 | |
| Mirati Therapeutics | 2.8 | $137M | 850k | 161.53 | |
| Alnylam Pharmaceuticals (ALNY) | 2.6 | $127M | 750k | 169.52 | |
| General Motors Company Call Option (GM) | 2.4 | $118M | 2.0M | 59.17 | |
| Fate Therapeutics (FATE) | 2.4 | $117M | 1.4M | 86.79 | |
| Rubius Therapeutics | 2.3 | $113M | 4.6M | 24.41 | |
| Morphic Hldg (MORF) | 2.1 | $104M | 1.8M | 57.39 | |
| Igm Biosciences (IGMS) | 1.9 | $92M | 1.1M | 83.20 | |
| Generation Bio | 1.5 | $76M | 2.8M | 26.90 | |
| Intel Corporation Call Option (INTC) | 1.5 | $73M | 1.3M | 56.14 | |
| Bristol Myers Squibb Call Option (BMY) | 1.4 | $67M | 1.0M | 66.82 | |
| I Mab Sponsored Ads (IMAB) | 1.3 | $63M | 750k | 83.95 | |
| Schrodinger (SDGR) | 1.2 | $60M | 797k | 75.61 | |
| Scholar Rock Hldg Corp (SRRK) | 1.2 | $58M | 2.0M | 28.90 | |
| Sage Therapeutics (SAGE) | 1.2 | $57M | 1.0M | 56.81 | |
| Ford Motor Company Call Option (F) | 1.1 | $52M | 3.5M | 14.86 | |
| Cerevel Therapeutics Hldng I (CERE) | 1.0 | $51M | 2.0M | 25.62 | |
| Allovir (ALVR) | 0.9 | $46M | 2.3M | 19.74 | |
| Springworks Therapeutics (SWTX) | 0.8 | $41M | 500k | 82.41 | |
| Intellia Therapeutics (NTLA) | 0.8 | $41M | 250k | 161.91 | |
| Denali Therapeutics (DNLI) | 0.8 | $39M | 500k | 78.44 | |
| Biohaven Pharmaceutical Holding | 0.8 | $39M | 400k | 97.08 | |
| Oatly Group Ab Sponsored Ads | 0.7 | $37M | 1.5M | 24.46 | |
| Amicus Therapeutics (FOLD) | 0.7 | $36M | 3.8M | 9.64 | |
| Replimune Group (REPL) | 0.7 | $35M | 900k | 38.42 | |
| Krystal Biotech (KRYS) | 0.7 | $34M | 500k | 68.00 | |
| Agenus Com New | 0.7 | $33M | 6.0M | 5.49 | |
| Kronos Bio | 0.6 | $32M | 1.3M | 23.95 | |
| Tg Therapeutics (TGTX) | 0.6 | $31M | 800k | 38.79 | |
| Talaris Therapeutics | 0.6 | $30M | 2.1M | 14.69 | |
| Verve Therapeutics (VERV) | 0.6 | $30M | 500k | 60.25 | |
| Dicerna Pharmaceuticals | 0.6 | $30M | 800k | 37.32 | |
| Freeport-mcmoran CL B Call Option (FCX) | 0.6 | $28M | 750k | 37.11 | |
| Alx Oncology Hldgs (ALXO) | 0.6 | $27M | 500k | 54.68 | |
| Turning Point Therapeutics I | 0.6 | $27M | 350k | 78.02 | |
| Iteos Therapeutics | 0.5 | $26M | 994k | 25.65 | |
| Forma Therapeutics Hldgs SHS | 0.5 | $25M | 1.0M | 24.89 | |
| Trillium Therapeutics Com New | 0.5 | $24M | 2.5M | 9.70 | |
| Avis Budget (CAR) | 0.5 | $23M | 300k | 77.89 | |
| Atara Biotherapeutics | 0.5 | $23M | 1.5M | 15.55 | |
| Sqz Biotech (SQZB) | 0.5 | $23M | 1.6M | 14.45 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.4 | $22M | 2.3M | 9.79 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.4 | $22M | 1.0M | 21.20 | |
| Praxis Precision Medicines I | 0.4 | $22M | 1.2M | 18.28 | |
| Ikena Oncology (IKNA) | 0.4 | $22M | 1.5M | 14.04 | |
| Graphite Bio | 0.4 | $22M | 700k | 30.73 | |
| Albireo Pharma | 0.4 | $21M | 600k | 35.18 | |
| Novagold Res Com New (NG) | 0.4 | $21M | 2.6M | 8.01 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $20M | 1.6M | 12.19 | |
| Neximmune | 0.4 | $20M | 1.2M | 16.32 | |
| Gossamer Bio (GOSS) | 0.4 | $19M | 2.4M | 8.12 | |
| Foghorn Therapeutics (FHTX) | 0.4 | $18M | 1.7M | 10.67 | |
| Marinus Pharmaceuticals Com New | 0.4 | $18M | 1.0M | 17.94 | |
| Aptinyx | 0.4 | $17M | 6.1M | 2.83 | |
| Repare Therapeutics Ord (RPTX) | 0.3 | $17M | 550k | 31.18 | |
| Bridgebio Pharma (BBIO) | 0.3 | $17M | 275k | 60.96 | |
| Selecta Biosciences | 0.3 | $17M | 4.0M | 4.18 | |
| Ambrx Biopharma Sponsored Ads | 0.3 | $17M | 850k | 19.60 | |
| Mersana Therapeutics | 0.3 | $16M | 1.2M | 13.58 | |
| Zymeworks | 0.3 | $16M | 450k | 34.69 | |
| Iqiyi Sponsored Ads (IQ) | 0.3 | $16M | 1.0M | 15.58 | |
| Dlocal Class A Com (DLO) | 0.3 | $16M | 295k | 52.53 | |
| Bellus Health Com New | 0.3 | $15M | 4.8M | 3.11 | |
| Relay Therapeutics (RLAY) | 0.3 | $15M | 400k | 36.59 | |
| Lifestance Health Group (LFST) | 0.3 | $14M | 500k | 27.86 | |
| Harpoon Therapeutics | 0.3 | $14M | 1.0M | 13.87 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.3 | $14M | 1.0M | 13.78 | |
| Translate Bio | 0.3 | $14M | 500k | 27.54 | |
| Evelo Biosciences | 0.3 | $14M | 1.0M | 13.74 | |
| Adagene Ads (ADAG) | 0.3 | $14M | 1.0M | 13.56 | |
| Y Mabs Therapeutics | 0.3 | $14M | 400k | 33.80 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $13M | 1.0M | 12.96 | |
| Kura Oncology (KURA) | 0.3 | $13M | 600k | 20.85 | |
| Tcr2 Therapeutics Inc cs | 0.2 | $12M | 750k | 16.41 | |
| Agilon Health (AGL) | 0.2 | $12M | 300k | 40.57 | |
| Kymera Therapeutics (KYMR) | 0.2 | $12M | 250k | 48.50 | |
| Lyell Immunopharma | 0.2 | $11M | 700k | 16.24 | |
| Dyne Therapeutics (DYN) | 0.2 | $11M | 525k | 21.04 | |
| Cyclerion Therapeutics | 0.2 | $11M | 2.8M | 3.90 | |
| Adverum Biotechnologies | 0.2 | $11M | 3.0M | 3.50 | |
| Curis Com New | 0.2 | $11M | 1.3M | 8.07 | |
| Vor Biopharma (VOR) | 0.2 | $10M | 550k | 18.65 | |
| Cytokinetics Com New (CYTK) | 0.2 | $9.9M | 500k | 19.79 | |
| Ovid Therapeutics (OVID) | 0.2 | $9.8M | 2.5M | 3.91 | |
| Syros Pharmaceuticals | 0.2 | $9.3M | 1.7M | 5.45 | |
| Blueprint Medicines (BPMC) | 0.2 | $8.8M | 100k | 87.96 | |
| 111 Ads | 0.2 | $8.8M | 966k | 9.08 | |
| Instil Bio | 0.2 | $8.7M | 450k | 19.32 | |
| Immunic (IMUX) | 0.2 | $8.6M | 700k | 12.26 | |
| Stoke Therapeutics (STOK) | 0.2 | $8.4M | 250k | 33.66 | |
| Applied Therapeutics (APLT) | 0.2 | $8.3M | 400k | 20.78 | |
| Solid Biosciences | 0.2 | $8.2M | 2.3M | 3.66 | |
| Design Therapeutics (DSGN) | 0.2 | $8.0M | 400k | 19.89 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $7.9M | 1.0M | 7.93 | |
| Orchard Therapeutics Ads | 0.2 | $7.9M | 1.8M | 4.39 | |
| Sana Biotechnology (SANA) | 0.2 | $7.9M | 400k | 19.66 | |
| Aravive | 0.2 | $7.8M | 1.3M | 5.98 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $7.8M | 200k | 39.05 | |
| Omega Alpha Spac Cl A | 0.2 | $7.5M | 750k | 9.95 | |
| Deciphera Pharmaceuticals | 0.1 | $7.3M | 200k | 36.61 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $7.3M | 200k | 36.50 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $7.3M | 261k | 27.98 | |
| Aeglea Biotherapeutics | 0.1 | $7.3M | 1.0M | 6.96 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $7.1M | 400k | 17.69 | |
| Spero Therapeutics (SPRO) | 0.1 | $7.0M | 500k | 13.96 | |
| Contrafect Corp Com New | 0.1 | $6.6M | 1.5M | 4.40 | |
| Fusion Pharmaceuticals | 0.1 | $6.1M | 750k | 8.08 | |
| Hookipa Pharma Inc equity | 0.1 | $5.5M | 600k | 9.16 | |
| Alpine Immune Sciences | 0.1 | $5.3M | 593k | 9.00 | |
| Bright Health Group | 0.1 | $5.2M | 306k | 17.16 | |
| Cardiff Oncology (CRDF) | 0.1 | $5.0M | 750k | 6.65 | |
| Dynamics Special Purpose Cor Class A Com | 0.1 | $5.0M | 500k | 9.94 | |
| Leap Therapeutics | 0.1 | $4.9M | 3.0M | 1.64 | |
| Aldeyra Therapeutics (ALDX) | 0.1 | $4.9M | 432k | 11.33 | |
| Seres Therapeutics | 0.1 | $4.8M | 200k | 23.85 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $4.8M | 1.5M | 3.17 | |
| Immutep Sponsored Ads (IMMP) | 0.1 | $3.9M | 1.0M | 3.87 | |
| Kaleido Biosciences Ord (KLDO) | 0.1 | $3.7M | 501k | 7.44 | |
| Codiak Biosciences | 0.1 | $3.7M | 200k | 18.53 | |
| Avidity Biosciences Ord (RNA) | 0.1 | $3.5M | 143k | 24.71 | |
| Metacrine Ord | 0.1 | $3.5M | 925k | 3.80 | |
| Viacomcbs CL B (PARA) | 0.1 | $3.4M | 75k | 45.20 | |
| Sigilon Therapeutics | 0.1 | $3.0M | 276k | 10.73 | |
| Kinnate Biopharma | 0.1 | $2.9M | 125k | 23.28 | |
| Axcella Health Inc equity | 0.1 | $2.9M | 713k | 4.01 | |
| Mei Pharma Com New | 0.1 | $2.9M | 1.0M | 2.85 | |
| Cullinan Oncology (CGEM) | 0.1 | $2.6M | 100k | 25.75 | |
| Chinook Therapeutics | 0.1 | $2.5M | 181k | 14.12 | |
| Yumanity Therapeutics | 0.1 | $2.5M | 217k | 11.65 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $2.2M | 200k | 10.88 | |
| Molecular Partners Ads (MOLN) | 0.0 | $2.0M | 100k | 20.49 | |
| Chiasma | 0.0 | $1.8M | 380k | 4.73 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.4M | 111k | 12.87 | |
| Rigel Pharmaceuticals Com New | 0.0 | $1.4M | 321k | 4.34 | |
| Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.0 | $1.1M | 80k | 14.38 | |
| Surface Oncology | 0.0 | $746k | 100k | 7.46 | |
| Lufax Holding Ads Rep Shs Cl A | 0.0 | $565k | 50k | 11.30 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $454k | 225k | 2.02 |